Author:
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Chen MG, Mott KE, 1990. Progress in assessment of morbidity due to Fasciola hepatica infection: a review of recent literature. Trop Dis Bull 87 :R1–R38.
-
2
WHO, 1995. Control of foodborne trematode infections. World Health Organ Tech Rep Ser 849 :1–157.
-
3
Mas-Coma S, Esteban JG, Bargues MD, 1999. Epidemiology of human fascioliasis: a review and proposed new classification. Bull WHO 77 :340–346.
-
4
Mas-Coma S, Bargues MD, Esteban JG, 1999. Human fasciolosis. Dalton JP, ed. Fasciolosis. Wallingford, UK: CABI Publishing, 411–434.
-
5
Mas-Coma S, 2004. Human fascioliasis. Cotruvo JA, Dufour A, Rees G, Bartram J, Carr R, Cliver DO, Craun GF, Fayer R, Gannon VPJ, eds. World Health Organization (WHO), Water-borne Zoonoses: Identification, Causes and Control. Chapter 19. London, UK: IWA Publishing, 305–322.
-
6
Rim HJ, Farag HF, Sornmani S, Cross JH, 1994. Food-borne trematodes: ignored or emerging? Parasitol Today 10 :207–209.
-
7
Hopkins DR, 1992. Homing in on helminths. Am J Trop Med Hyg 46 :626–634.
-
8
Mas-Coma S, Angles R, Esteban JG, Bargues MD, Buchon P, Franken M, Strauss W, 1999. The Northern Bolivian Altiplano: a region highly endemic for human fascioliasis. Trop Med Int Health 4 :454–467.
-
9
Esteban JG, Gonzales C, Bargues MD, Angles R, Sanchez C, Naquira C, Mas-Coma S, 2002. High fascioliasis infection in children linked to a man-made irrigation zone in Peru. Trop Med Int Health 7 :339–348.
-
10
Mas-Coma S, Bargues MD, Valero MA, 2005. Fascioliasis and other plantborne trematode zoonoses. Int J Parasitol 35 :1255–1278.
-
11
Mas-Coma S, Bargues MD, Marty AM, Neafie RC, 2000. Hepatic trematodiases. Meyers WM, Neafie RC, Marty AM, Wear DJ, eds. Pathology of Infectious Diseases, Vol. 1 Helminthiases. Washington DC: Armed Forces Institute of Pathology and American Registry of Pathology, 69–92.
-
12
Valero MA, Santana M, Morales M, Hernandez M, Mas-Coma S, 2003. Risk of gallstone disease in advanced chronic phase of fascioliasis: an experimental study in a rat model. J Inf Dis 188 :787–793.
-
13
Marcos LA, Maco V, Castillo M, Terashima A, Zerpa R, Gotuzzo E, 2005. Reporte de casos de fasciolosis en el Instituto Especializado de Salud del Niño Lima – Perú (1988–2003). Rev Gastroenterol Peru 25 :198–205.
-
14
Timoteo O, Maco V, Neyra V, Yi PJ, Leguia G, Espinoza JR, 2005. Characterization of the humoral immune response in alpacas (Lama pacos) experimentally infected with Fasciola hepatica against cysteine proteinases Fas1 and Fas2 and histopathological finding. Vet Immunol Immunopathol 106 :77–86.
-
15
Hillyer GV, 1999. Immunodiagnosis of human and animal fasciolosis. Dalton JP, ed. Fasciolosis. Wallingford, UK: CABI Publishing, 435–447.
-
16
Cordova M, Reategui L, Espinoza JR, 1999. Immunodiagnosis of human fascioliasis with Fasciola hepatica cysteine proteinases. Trans R Soc Trop Med Hyg 93 :54–57.
-
17
Hillyer GV, Soler de Galanes M, Rodríguez-Pérez J, Bjorland J, Silva de Lagrava M, Ramírez Guzmán S, Bryan RT, 1992. Use of the Falcon assay screening test-enzyme-linked immunosorbent assay (FAST-ELISA) and the enzyme-linked immuno-electrotransfer blot (EITB) to determine the prevalence of human fascioliasis in the Bolivian Altiplano. Am J Trop Med Hyg 46 :603–609.
-
18
Cordova M, Herrera P, Ñopo L, Bellatin J, Náquira C, Guerra H, Espinoza JR, 1997. Fasciola hepatica cysteine proteinases: immunodominant antigens in human fascioliasis. Am J Trop Med Hyg 57 :660–666.
-
19
O’Neill SM, Parkinson M, Strauss W, Angles R, Dalton JP, 1998. Immunodiagnosis of Fasciola hepatica infection (fascioliasis) in a human population in the Bolivian Altiplano using purified cathepsin L cysteine proteinase. Am J Trop Med Hyg 58 :417–423.
-
20
Knobloch J, Delgado E, Alvarez A, Reymann U, Bialek R, 1985. Human fasciolasis in Cajamarca/Perú. I. Diagnostic methods and treatment with praziquantel. Trop Med Parasitol 36 :88–90.
-
21
Marcos LA, Maco V, Terashima A, Samalvides F, Miranda E, Tantalean M, Espinoza JR, Gotuzzo E, 2004. Hiperendemicidad de fasciolosis humana en el Valle del Mantaro, Perú: factores de riesgo de la infección por Fasciola hepatica.Rev Gastroenterol Peru 24 :158–164.
-
22
Lumbreras H, Cantellar R, Burga R, 1962. Acerca de un procedimiento de sedimentación rápida para investigar huevos de Fasciola hepatica en las heces, su evaluación y uso en el campo. Rev. Méd. Peruana 31 :167–174.
-
23
Knight WB, Hiatt RA, Cline BL, Ritchie LS, 1976. A modification of the formol-ether concentration technique for increased sensitivity in detecting Schistosoma mansoni.Am J Trop Med Hyg 55 :818–823.
-
24
Ash LR, Orihel TC, Savioli L, 1994. Bench Aids for the Diagnosis of Intestinal Parasites. Geneva, World Health Organization.
-
25
Neyra V, Chavarri E, Espinoza JR, 2002. Cysteine proteinases Fas1 and Fas2 are diagnostic markers for Fasciola hepatica infection in alpacas (Lama pacos). Vet Parasitol 105 :21–32.
-
26
Norman GR, Streiner DL, 1996. Bioestadistíca. Rubes Editorial SL, ed. Madrid: Harcourt Brace de España, S.A., 150–162.
-
27
Strauss W, O’Neill SM, Parkinson M, Angles R, Dalton JP, 1999. Diagnosis of human fascioliasis: detection of anti-cathepsin L antibodies in blood samples collected on filter paper. Am J Trop Med Hyg 60 :746–748.
-
28
Reichel MP, Vanhoff K, Baxter B, 2005. Performance characteristics of an enzyme-linked immunosorbent assay performed in milk for the detection of liver fluke (Fasciola hepatica) infection in cattle. Vet Parasitol 129 :61–66.
-
29
Doenhoff MJ, Chiodini PL, Hamilton JW, 2004. Specific and sensitive diagnosis of schistosome infection: can it be done with antibodies? Trends Parasitol 20 :35–39.
-
30
Carnevale S, Rodriguez MI, Guarnera EA, Carmona C, Tanos T, Angel SO, 2001. Immunodiagnosis of fasciolosis using recombinant procathepsin L cysteine proteinase. Diagn Microbiol Infect Dis 41 :43–49.
-
31
O’Neill SM, Parkinson M, Dowd AJ, Strauss W, Angles R, Dalton JP, 1999. Immunodiagnosis of human fascioliasis using recombinant Fasciola hepatica cathepsin L1 cysteine proteinase. Am J Trop Med Hyg 60 :749–751.
-
32
Rokni MB, Massoud J, O’Neill SM, Parkinson M, Dalton JP, 2002. Diagnosis of human fasciolosis in the Gilan province of Northern Iran: application of cathepsin L-ELISA. Diagn Microbiol Inf Dis 44 :175–179.
-
33
Esteban JG, Gonzalez C, Curtale F, Muñoz-Antoli C, Valero MA, Bargues MD, El Sayed M, El Wakeel A, Abdel-Wahab Y, Montresor A, Engels D, Savioli L, Mas-Coma S, 2003. Hyperendemic fascioliasis associated with schistosomiasis in villages of the Nile Delta, Egypt. Am J Trop Med Hyg 69 :429–437.
-
34
Moghaddam AS, Massoud J, Mahmoodi M, Mahvi AH, Periago MV, Artigas P, Fuentes MV, Bargues MD, Mas-Coma S, 2004. Human and animal fascioliasis in Mazandaran province, northern Iran. Parasitol Res 94 :61–69.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1391 | 1298 | 86 |
| Full Text Views | 413 | 18 | 2 |
| PDF Downloads | 141 | 17 | 2 |
EVALUATION OF FAS2-ELISA FOR THE SEROLOGICAL DETECTION OF FASCIOLA HEPATICA INFECTION IN HUMANS
JOSE R. ESPINOZA
JOSE R. ESPINOZA
Unit of Molecular Biotechnology, Laboratorios de Investigación y Desarrollo (LID), Facultad de Ciencias y Filosofia; Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru; Departamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain
Search for other papers by JOSE R. ESPINOZA in
Current site
Google Scholar
PubMed
Search for other papers by JOSE R. ESPINOZA in
Current site
Google Scholar
PubMed
VICENTE MACO
VICENTE MACO
Unit of Molecular Biotechnology, Laboratorios de Investigación y Desarrollo (LID), Facultad de Ciencias y Filosofia; Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru; Departamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain
Search for other papers by VICENTE MACO in
Current site
Google Scholar
PubMed
Search for other papers by VICENTE MACO in
Current site
Google Scholar
PubMed
LUIS MARCOS
LUIS MARCOS
Unit of Molecular Biotechnology, Laboratorios de Investigación y Desarrollo (LID), Facultad de Ciencias y Filosofia; Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru; Departamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain
Search for other papers by LUIS MARCOS in
Current site
Google Scholar
PubMed
Search for other papers by LUIS MARCOS in
Current site
Google Scholar
PubMed
SANDRA SAEZ
SANDRA SAEZ
Unit of Molecular Biotechnology, Laboratorios de Investigación y Desarrollo (LID), Facultad de Ciencias y Filosofia; Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru; Departamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain
Search for other papers by SANDRA SAEZ in
Current site
Google Scholar
PubMed
Search for other papers by SANDRA SAEZ in
Current site
Google Scholar
PubMed
VICTOR NEYRA
VICTOR NEYRA
Unit of Molecular Biotechnology, Laboratorios de Investigación y Desarrollo (LID), Facultad de Ciencias y Filosofia; Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru; Departamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain
Search for other papers by VICTOR NEYRA in
Current site
Google Scholar
PubMed
Search for other papers by VICTOR NEYRA in
Current site
Google Scholar
PubMed
ANGELICA TERASHIMA
ANGELICA TERASHIMA
Unit of Molecular Biotechnology, Laboratorios de Investigación y Desarrollo (LID), Facultad de Ciencias y Filosofia; Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru; Departamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain
Search for other papers by ANGELICA TERASHIMA in
Current site
Google Scholar
PubMed
Search for other papers by ANGELICA TERASHIMA in
Current site
Google Scholar
PubMed
FRINE SAMALVIDES
FRINE SAMALVIDES
Unit of Molecular Biotechnology, Laboratorios de Investigación y Desarrollo (LID), Facultad de Ciencias y Filosofia; Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru; Departamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain
Search for other papers by FRINE SAMALVIDES in
Current site
Google Scholar
PubMed
Search for other papers by FRINE SAMALVIDES in
Current site
Google Scholar
PubMed
EDUARDO GOTUZZO
EDUARDO GOTUZZO
Unit of Molecular Biotechnology, Laboratorios de Investigación y Desarrollo (LID), Facultad de Ciencias y Filosofia; Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru; Departamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain
Search for other papers by EDUARDO GOTUZZO in
Current site
Google Scholar
PubMed
Search for other papers by EDUARDO GOTUZZO in
Current site
Google Scholar
PubMed
ELIZABETH CHAVARRY
ELIZABETH CHAVARRY
Unit of Molecular Biotechnology, Laboratorios de Investigación y Desarrollo (LID), Facultad de Ciencias y Filosofia; Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru; Departamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain
Search for other papers by ELIZABETH CHAVARRY in
Current site
Google Scholar
PubMed
Search for other papers by ELIZABETH CHAVARRY in
Current site
Google Scholar
PubMed
MARIA CECILIA HUAMAN
MARIA CECILIA HUAMAN
Unit of Molecular Biotechnology, Laboratorios de Investigación y Desarrollo (LID), Facultad de Ciencias y Filosofia; Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru; Departamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain
Search for other papers by MARIA CECILIA HUAMAN in
Current site
Google Scholar
PubMed
Search for other papers by MARIA CECILIA HUAMAN in
Current site
Google Scholar
PubMed
M. DOLORES BARGUES
M. DOLORES BARGUES
Unit of Molecular Biotechnology, Laboratorios de Investigación y Desarrollo (LID), Facultad de Ciencias y Filosofia; Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru; Departamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain
Search for other papers by M. DOLORES BARGUES in
Current site
Google Scholar
PubMed
Search for other papers by M. DOLORES BARGUES in
Current site
Google Scholar
PubMed
M. ADELA VALERO
M. ADELA VALERO
Unit of Molecular Biotechnology, Laboratorios de Investigación y Desarrollo (LID), Facultad de Ciencias y Filosofia; Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru; Departamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain
Search for other papers by M. ADELA VALERO in
Current site
Google Scholar
PubMed
Search for other papers by M. ADELA VALERO in
Current site
Google Scholar
PubMed
SANTIAGO MAS-COMA
SANTIAGO MAS-COMA
Unit of Molecular Biotechnology, Laboratorios de Investigación y Desarrollo (LID), Facultad de Ciencias y Filosofia; Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru; Departamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain
Search for other papers by SANTIAGO MAS-COMA in
Current site
Google Scholar
PubMed
Search for other papers by SANTIAGO MAS-COMA in
Current site
Google Scholar
PubMed
The performance of Fas2-ELISA for the diagnosis of Fasciola hepatica infection in children living in areas of high endemicity for fascioliasis in the Peruvian Andes is analyzed. Fas2-ELISA is based on the detection of circulating IgG antibodies elicited in infected individuals against a F. hepatica antigen termed Fas2. The study was conducted in three Andean localities, Huertas-Julcan in Junin, Asillo in Puno, and Cajamarca, with a total population of 634 children in an age range 1 to 16 years old. Child fascioliasis prevalence was 21.1% in Huertas-Julcan, 25.4% in Asillo, and 24% in Cajamarca, estimated by coprological inspection. The seroprevalence of F. hepatica infection, determined by Fas2-ELISA, was 27.8% in Huertas-Julcan, 44.6% in Asillo, and 29.1% in Cajamarca. The overall sensitivity of Fas2-ELISA was 92.4%, the specificity 83.6%, and the negative predictive value 97.2%. No association between OD450 Fas2-ELISA and infection intensity measured by egg counting was observed. Results show that Fas2-ELISA is a highly sensitive immunodiagnostic test for the detection of F. hepatica infection in children living in human fascioliasis endemic areas.
Author Notes
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Chen MG, Mott KE, 1990. Progress in assessment of morbidity due to Fasciola hepatica infection: a review of recent literature. Trop Dis Bull 87 :R1–R38.
-
2
WHO, 1995. Control of foodborne trematode infections. World Health Organ Tech Rep Ser 849 :1–157.
-
3
Mas-Coma S, Esteban JG, Bargues MD, 1999. Epidemiology of human fascioliasis: a review and proposed new classification. Bull WHO 77 :340–346.
-
4
Mas-Coma S, Bargues MD, Esteban JG, 1999. Human fasciolosis. Dalton JP, ed. Fasciolosis. Wallingford, UK: CABI Publishing, 411–434.
-
5
Mas-Coma S, 2004. Human fascioliasis. Cotruvo JA, Dufour A, Rees G, Bartram J, Carr R, Cliver DO, Craun GF, Fayer R, Gannon VPJ, eds. World Health Organization (WHO), Water-borne Zoonoses: Identification, Causes and Control. Chapter 19. London, UK: IWA Publishing, 305–322.
-
6
Rim HJ, Farag HF, Sornmani S, Cross JH, 1994. Food-borne trematodes: ignored or emerging? Parasitol Today 10 :207–209.
-
7
Hopkins DR, 1992. Homing in on helminths. Am J Trop Med Hyg 46 :626–634.
-
8
Mas-Coma S, Angles R, Esteban JG, Bargues MD, Buchon P, Franken M, Strauss W, 1999. The Northern Bolivian Altiplano: a region highly endemic for human fascioliasis. Trop Med Int Health 4 :454–467.
-
9
Esteban JG, Gonzales C, Bargues MD, Angles R, Sanchez C, Naquira C, Mas-Coma S, 2002. High fascioliasis infection in children linked to a man-made irrigation zone in Peru. Trop Med Int Health 7 :339–348.
-
10
Mas-Coma S, Bargues MD, Valero MA, 2005. Fascioliasis and other plantborne trematode zoonoses. Int J Parasitol 35 :1255–1278.
-
11
Mas-Coma S, Bargues MD, Marty AM, Neafie RC, 2000. Hepatic trematodiases. Meyers WM, Neafie RC, Marty AM, Wear DJ, eds. Pathology of Infectious Diseases, Vol. 1 Helminthiases. Washington DC: Armed Forces Institute of Pathology and American Registry of Pathology, 69–92.
-
12
Valero MA, Santana M, Morales M, Hernandez M, Mas-Coma S, 2003. Risk of gallstone disease in advanced chronic phase of fascioliasis: an experimental study in a rat model. J Inf Dis 188 :787–793.
-
13
Marcos LA, Maco V, Castillo M, Terashima A, Zerpa R, Gotuzzo E, 2005. Reporte de casos de fasciolosis en el Instituto Especializado de Salud del Niño Lima – Perú (1988–2003). Rev Gastroenterol Peru 25 :198–205.
-
14
Timoteo O, Maco V, Neyra V, Yi PJ, Leguia G, Espinoza JR, 2005. Characterization of the humoral immune response in alpacas (Lama pacos) experimentally infected with Fasciola hepatica against cysteine proteinases Fas1 and Fas2 and histopathological finding. Vet Immunol Immunopathol 106 :77–86.
-
15
Hillyer GV, 1999. Immunodiagnosis of human and animal fasciolosis. Dalton JP, ed. Fasciolosis. Wallingford, UK: CABI Publishing, 435–447.
-
16
Cordova M, Reategui L, Espinoza JR, 1999. Immunodiagnosis of human fascioliasis with Fasciola hepatica cysteine proteinases. Trans R Soc Trop Med Hyg 93 :54–57.
-
17
Hillyer GV, Soler de Galanes M, Rodríguez-Pérez J, Bjorland J, Silva de Lagrava M, Ramírez Guzmán S, Bryan RT, 1992. Use of the Falcon assay screening test-enzyme-linked immunosorbent assay (FAST-ELISA) and the enzyme-linked immuno-electrotransfer blot (EITB) to determine the prevalence of human fascioliasis in the Bolivian Altiplano. Am J Trop Med Hyg 46 :603–609.
-
18
Cordova M, Herrera P, Ñopo L, Bellatin J, Náquira C, Guerra H, Espinoza JR, 1997. Fasciola hepatica cysteine proteinases: immunodominant antigens in human fascioliasis. Am J Trop Med Hyg 57 :660–666.
-
19
O’Neill SM, Parkinson M, Strauss W, Angles R, Dalton JP, 1998. Immunodiagnosis of Fasciola hepatica infection (fascioliasis) in a human population in the Bolivian Altiplano using purified cathepsin L cysteine proteinase. Am J Trop Med Hyg 58 :417–423.
-
20
Knobloch J, Delgado E, Alvarez A, Reymann U, Bialek R, 1985. Human fasciolasis in Cajamarca/Perú. I. Diagnostic methods and treatment with praziquantel. Trop Med Parasitol 36 :88–90.
-
21
Marcos LA, Maco V, Terashima A, Samalvides F, Miranda E, Tantalean M, Espinoza JR, Gotuzzo E, 2004. Hiperendemicidad de fasciolosis humana en el Valle del Mantaro, Perú: factores de riesgo de la infección por Fasciola hepatica.Rev Gastroenterol Peru 24 :158–164.
-
22
Lumbreras H, Cantellar R, Burga R, 1962. Acerca de un procedimiento de sedimentación rápida para investigar huevos de Fasciola hepatica en las heces, su evaluación y uso en el campo. Rev. Méd. Peruana 31 :167–174.
-
23
Knight WB, Hiatt RA, Cline BL, Ritchie LS, 1976. A modification of the formol-ether concentration technique for increased sensitivity in detecting Schistosoma mansoni.Am J Trop Med Hyg 55 :818–823.
-
24
Ash LR, Orihel TC, Savioli L, 1994. Bench Aids for the Diagnosis of Intestinal Parasites. Geneva, World Health Organization.
-
25
Neyra V, Chavarri E, Espinoza JR, 2002. Cysteine proteinases Fas1 and Fas2 are diagnostic markers for Fasciola hepatica infection in alpacas (Lama pacos). Vet Parasitol 105 :21–32.
-
26
Norman GR, Streiner DL, 1996. Bioestadistíca. Rubes Editorial SL, ed. Madrid: Harcourt Brace de España, S.A., 150–162.
-
27
Strauss W, O’Neill SM, Parkinson M, Angles R, Dalton JP, 1999. Diagnosis of human fascioliasis: detection of anti-cathepsin L antibodies in blood samples collected on filter paper. Am J Trop Med Hyg 60 :746–748.
-
28
Reichel MP, Vanhoff K, Baxter B, 2005. Performance characteristics of an enzyme-linked immunosorbent assay performed in milk for the detection of liver fluke (Fasciola hepatica) infection in cattle. Vet Parasitol 129 :61–66.
-
29
Doenhoff MJ, Chiodini PL, Hamilton JW, 2004. Specific and sensitive diagnosis of schistosome infection: can it be done with antibodies? Trends Parasitol 20 :35–39.
-
30
Carnevale S, Rodriguez MI, Guarnera EA, Carmona C, Tanos T, Angel SO, 2001. Immunodiagnosis of fasciolosis using recombinant procathepsin L cysteine proteinase. Diagn Microbiol Infect Dis 41 :43–49.
-
31
O’Neill SM, Parkinson M, Dowd AJ, Strauss W, Angles R, Dalton JP, 1999. Immunodiagnosis of human fascioliasis using recombinant Fasciola hepatica cathepsin L1 cysteine proteinase. Am J Trop Med Hyg 60 :749–751.
-
32
Rokni MB, Massoud J, O’Neill SM, Parkinson M, Dalton JP, 2002. Diagnosis of human fasciolosis in the Gilan province of Northern Iran: application of cathepsin L-ELISA. Diagn Microbiol Inf Dis 44 :175–179.
-
33
Esteban JG, Gonzalez C, Curtale F, Muñoz-Antoli C, Valero MA, Bargues MD, El Sayed M, El Wakeel A, Abdel-Wahab Y, Montresor A, Engels D, Savioli L, Mas-Coma S, 2003. Hyperendemic fascioliasis associated with schistosomiasis in villages of the Nile Delta, Egypt. Am J Trop Med Hyg 69 :429–437.
-
34
Moghaddam AS, Massoud J, Mahmoodi M, Mahvi AH, Periago MV, Artigas P, Fuentes MV, Bargues MD, Mas-Coma S, 2004. Human and animal fascioliasis in Mazandaran province, northern Iran. Parasitol Res 94 :61–69.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1391 | 1298 | 86 |
| Full Text Views | 413 | 18 | 2 |
| PDF Downloads | 141 | 17 | 2 |